Ameriprise
ALT icon

Ameriprise’s Altimmune ALT Stock Holding History

Ameriprise’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
68,571
-3,397
-5% -$10.1K ﹤0.01% 3952
2026
Q1 		$222K Sell
71,968
-1,870
-3% -$7.94K ﹤0.01% 3849
2025
Q4 		$267K Sell
73,838
-474
-0.6% -$2.07K ﹤0.01% 3843
2025
Q3 		$280K Sell
74,312
-39,563
-35% -$153K ﹤0.01% 3819
2025
Q2 		$441K Sell
113,875
-1,330,057
-92% -$7.2M ﹤0.01% 3569
2025
Q1 		$7.22M Sell
1,443,932
-3,810,966
-73% -$24.1M ﹤0.01% 2017
2024
Q4 		$37.9M Buy
5,254,898
+1,378,854
+36% +$10.5M 0.01% 985
2024
Q3 		$23.8M Buy
3,876,044
+652,047
+20% +$4.42M 0.01% 1223
2024
Q2 		$21.4M Buy
3,223,997
+1,514,693
+89% +$11.2M 0.01% 1234
2024
Q1 		$17.4M Sell
1,709,304
-2,474,378
-59% -$25.2M ﹤0.01% 1389
2023
Q4 		$47.1M Buy
4,183,682
+4,172,791
+38,314% +$17.4M 0.01% 803
2023
Q3 		$28.3K Sell
10,891
-764
-7% -$2.19K ﹤0.01% 3859
2023
Q2 		$41.1K Sell
11,655
-1,047
-8% -$4.7K ﹤0.01% 3873
2023
Q1 		$53.6K Sell
12,702
-930
-7% -$11K ﹤0.01% 3867
2022
Q4 		$224K Buy
+13,632
New +$153K ﹤0.01% 3678
2021
Q2 		– Sell
-31,382
Closed -$443K – 3884
2021
Q1 		$443K Buy
+31,382
New +$507K ﹤0.01% 3452
2017
Q2 		– Sell
-54
Closed -$11K – 3722
2017
Q1 		$11K Buy
+54
New +$28.9K ﹤0.01% 3596

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise's ALT Position: Q2 2026 in Review

Ameriprise reduced its Altimmune (ALT) stake by 4.7% in Q2 2026, selling an estimated $10.1K and leaving 68,571 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #3952.

Ameriprise first reported a position in ALT in Q1 2017 and has held it in 17 quarters since. The position peaked at $47.1M in Q4 2023. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Ameriprise held 68,571 shares of Altimmune worth $208K as of Q2 2026.
  • Ameriprise sold 3,397 Altimmune shares in Q2 2026, an estimated $10.1K.
  • Altimmune made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3952 holding.
  • Ameriprise first reported a position in Altimmune in Q1 2017 and has held it in 17 quarters since.
  • Ameriprise's Altimmune position peaked at $47.1M in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.